← Eichor
Study identifier: NCT07208318 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Restructuring the Alpha-Gamma Code in Aging Vision

Condition: Aging · Visual Perception · Noninvasive Brain Stimulation  ·  Sponsor: Boston University Charles River Campus

PhaseEARLY_Phase 1
Planned participants240
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersYes

About this study

Tests whether age-related visual deficits arise from disrupted alpha-gamma coupling in visual cortex (V1) and MT. Uses fMRI, source-resolved HD-EEG, and personalized complex-waveform HD-tACS to (1) quantify aging effects on phase-amplitude coupling, (2) drive PAC into a preferred "gamma-at-alpha-troughs" state, and (3) bidirectionally change perception by aligning gamma to alpha troughs vs peaks. Two five-day, double-blind, sham-controlled studies (n=120 each) target contrast sensitivity (V1) and 3D shape-from-motion (MT), aiming for mechanistic insight and remediation in older adults with implications for ADRD.

This description comes directly from the study's public registry record.

Talk to the study team

Robert Reinhart, PhD  ·  (617) 353-9481  ·  rmgr@bu.edu

Always discuss trial participation with your own doctor first.

Locations (1)

111 Cummington Mall, Boston UniversityBoston, Massachusetts, United StatesRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07208318